-+ 0.00%
-+ 0.00%
-+ 0.00%
BioNTech names ex-Sobi chief Guido Oelkers as CEO, succeeding Ugur Sahin
Share
Listen to the news
BioNTech names ex-Sobi chief Guido Oelkers as CEO, succeeding Ugur Sahin
  • BioNTech named Guido Oelkers as chief executive, set to take office by Feb. 1, 2027, succeeding co-founder Ugur Sahin.
  • Oelkers joins from Swedish Orphan Biovitrum, where he has been CEO since 2017; he has 30+ years in biotech and pharma leadership.
  • Chief Medical Officer Ozlem Tureci will move to the management of a new standalone company to be led with Sahin; a successor search is underway.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608030500OMX_____CNEWS_DE_GNW1001255719_de) on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending